Navigation Links
Biotech IPOs bring in encouraging sums

CHICAGO In last weeks column, I raised the premise that in the early years of biotech it wasnt about making money but about providing radically new solutions to health care.

Theres a thread drawn to the early years of rock n roll where it was also not about making money but about expressing what was going on in society (without getting jailed for it). Today......

Full article >>> funding ($2.8 billion). The IPO market through mid-year 2003 raised $1.3 billion versus levels of less than $500 million for each of the three preceding years. The IPO market will be hard-pressed to achieve the record levels of 2000, which skyrocketed to $6.5 billion.



The problem with the above chart is that most of the financing is for large cap biotech compa......

Full article >>> Canada, France and even the Czech Republic and India. This makes for a total of 25 international IPOs versus 34 in the U.S.

I cant stress enough the importance of these IPOs. Other than an acquisition by a large biotech company or Big Pharma, this is the only way for the VC investors to exit from their investments in companies and replenish their financial coffers, attract new investors......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 09/22/04


Related biology technology :

1. Biotech officials praise focus of new venture fund
2. Biotech executive books a career flight thats closer to home
3. Gala Biotech among companies sold for $3.3 billion
4. Biotech with Madison ties raises $21M in capital
5. Biotech firm uses live heart tissue in drug screens
6. Biotech talent drew venture-funded firm to Madison
7. Biotech firm has strokes, Alzheimers in its sights
8. 42 days until the 2006 Olympics of Biotechnology in Chicago
9. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
10. Biotech leads list of top U.S. companies to work for
11. Biotech flourishes in 2005 while Big Pharma is on the decline
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 ... Inc., a privately-held immunotherapeutics company targeting infectious diseases, ... for the merger of PharmAthene and Altimmune in ... Venture Fund, HealthCap, Truffle Capital and Redmont Capital. ... diversified immunotherapeutics company with four clinical stage and ...
(Date:1/19/2017)... Mass. , Jan. 19, 2017 AquaBounty ... focused on enhancing productivity in aquaculture and a majority-owned ... announces that it has completed the listing of its ... the equity subscription from Intrexon. "AquaBounty,s listing ... that will broaden our exposure to the U.S. markets ...
(Date:1/19/2017)... Linda, Ca (PRWEB) , ... January 18, 2017 ... ... virtual events for tech innovators, engineers, and scientists from around the world, was ... American News. The awards program is based entirely on merit and decided upon ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... with services spanning the full spectrum of drug and device development, and ... to pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) ...
Breaking Biology Technology:
(Date:1/19/2017)... 2017 Sensory Inc ., a ... for consumer electronics, and i nnerCore ... cybersecurity solutions, today announced a global partnership that ... worldwide to bolster security of data sensitive mobile ... authentication platforms they offer, innerCore now offers its ...
(Date:1/13/2017)... 2017 Sandata Technologies, LLC, a leading ... industry, including Electronic Visit Verification™ (EVV™), announced today ... as Senior Vice President of Product Management. ... homecare experience to Sandata, where he will be ... align Sandata,s suite of solutions with the needs ...
(Date:1/12/2017)... and PUNE, India , January 12, 2017 ... Forecasts, 2015 - 2022," projects that the global biometric technology market is expected to ... 2016 to 2022. Continue Reading ... ...      ...
Breaking Biology News(10 mins):